investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identifying BRCA1 protein variants that provide resistance to therapy

Neil Johnson

4 Collaborator(s)

Funding source

National Cancer Institute (NIH)

James Duncan

Temple University Health System

Philadelphia, United States

Neil Johnson

Temple University Health System

Philadelphia, United States

Related projects

Fraser Symmans

Development of A Predictive Genomic Diagnostic Test for Survival Benefit from Everolimus (mTOR Inhibitor) Combined with Endocrine Therapy for Metastatic HR+/HER- Breast Cancer

Breast

Xiaojiang Cui

The Role of FOXC1 in Basal-Like Breast Cancer

Breast

Kylie Walters

Ubiquitin Signaling

Ovary

Pathology

Matthew P Goetz

Mayo Clinic Breast Cancer SPORE

Breast

Pathology

Aundrietta De Van Duncan

Understanding the Function of TRIM 24 in Mammary Epithelial Cells

Breast

Catherine Phelan

The Mitochondrial Genome and Ovarian Cancer Risk

Ovary

Pathology

Ralph Scully

Analysis of BRCA1 Recombination Functions

Breast

Amato J Giaccia

Tumor Hypoxia: Molecular Studies and Clinical Exploitation

Breast

Radiation Oncology

Dipak Panigrahy

Control of Cancer and Metastasis by Endothelial-Derived Epoxyeicosatrienoic Acids

Breast